Metropolis Healthcare Ltd Share Price
(METROPOLIS)
₹1678.1▲1.8%
as on 04:01PM, 20 Feb 2025
Metropolis Healthcare Ltd Performance
Day's Low
Day's High
₹1,625Day's Price Range₹1,704.7552 Week's Low
52 Week's High
₹1,551.0552-Week Price Range₹2,318.3
| Returns % | |
| 1 Month Return | -13.04 % |
| 3 Month Return | -18.22 % |
| 1 Year Return | -5.65 % |
| Market Stats | |
| Previous Close | ₹1,648.40 |
| Open | ₹1,648.40 |
| Volume | 4.01L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹8,453.18Cr |
Metropolis Healthcare Ltd Key Statistics
P/E Ratio
55.46
PEG Ratio
10.33
Market Cap
₹8,453.18 Cr
P/B Ratio
8.58
EPS
25.08
Dividend Yield
0.23
Sector
Healthcare
ROE
11.78
Metropolis Healthcare Ltd Mutual Fund Holdings
Metropolis Healthcare Ltd Analyst Rating
based on 17 analysts
68.75%
Buy
6.25%
Hold
25.00%
Sell
Based on 17 analysts offering long term price targets for Metropolis Healthcare Ltd. An average target of ₹2095.82
Source: S&P Global Market Intelligence
Metropolis Healthcare Ltd Share analysis
Metropolis Healthcare Ltd price forecast by 17 analysts
Upside of27.14%
High
₹2740
Target
₹2095.82
Low
₹1675
Metropolis Healthcare Ltd target price ₹2095.82, a slight upside of 27.14% compared to current price of ₹1678.1. According to 17 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Metropolis Healthcare Ltd revenue growth forecast
Expected growth rate Q1, FY2027:44.60%
Forecast
Actual
Including amortisation and stock based compensations
Metropolis Healthcare Ltd EPS growth forecast
EPS estimate Q1, FY2027:105.53%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Metropolis Healthcare Ltd
Metropolis Healthcare Faces Downward Pressure - 19 Feb, 2025
Metropolis Healthcare Ltd is experiencing significant downward trends, with recommendations to sell at ₹1,647 and a target of ₹1,515. The market conditions indicate continued volatility and weakness in the sector.ICICI Securities Upgrades Metropolis Healthcare to Buy - 11 Feb, 2025
ICICI Securities has upgraded Metropolis Healthcare to a 'Buy' rating with a revised target price of Rs 2,250, down from Rs 2,335. The company reported a net profit of Rs 31.47 crore for the latest quarter, with expectations of strong earnings growth over the next few years.Metropolis Healthcare Targets 15% Revenue Growth for FY25 - 06 Feb, 2025
Metropolis Healthcare's CEO projects a 15% revenue growth for FY25, supported by strong Q4 performance. Analysts have set target prices of Rs 2,250 and Rs 2,350, reflecting confidence in future growth despite recent EBITDA misses.Metropolis Healthcare Reports Strong Q3 Earnings Growth - 05 Feb, 2025
Metropolis Healthcare's Q3 FY25 results show a 15.4% increase in net profit to ₹31.4 crore, with revenue rising 10.9% to ₹322.8 crore. The company is focusing on regional growth through micro-market strategies and plans for acquisitions in North India.Metropolis Healthcare Reports Strong Q3 Results and New Initiatives - 04 Feb, 2025
Metropolis Healthcare reported a 15.4% YoY increase in net profit for Q3 FY25, alongside a revenue growth of 10.8%. The company appointed Sameer Patel as CFO and launched a self-sampling HPV DNA test in collaboration with Roche Diagnostics.Metropolis Launches HPV Test for Cervical Cancer Screening - 03 Feb, 2025
Metropolis Healthcare announced a collaboration with Roche Diagnostics to introduce a self-sampling HPV DNA test for cervical cancer screening, aiming to improve access across India, especially in underserved areas.Metropolis Healthcare Stock Faces Resistance and Support Levels - 31 Jan, 2025
Metropolis Healthcare stock is currently priced at Rs 1,794, facing resistance at Rs 1,869 and Rs 1,930. Support is noted at Rs 1,709, with a potential downside risk of 18.9%. A sustained drop below this support could lead to a decline towards Rs 1,455.Ameera Shah Advocates Calculated Risks for Growth - 21 Jan, 2025
Ameera Shah, promoter of Metropolis Healthcare, emphasizes the importance of taking calculated risks for financial stability, sharing her experience of increasing her stake through debt in 2015.
Insights on Metropolis Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 24.33% to 26.37% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 36.1% return, outperforming this stock by 41.7%
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 177.8% return, outperforming this stock by 194.4%
NEGATIVE IMPACTPrice Dip
In the last 3 years, METROPOLIS stock has moved down by -16.6%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 46.52 Cr → 31.36 Cr (in ₹), with an average decrease of 32.6% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 49.43% to 49.40% in Dec 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 3.99% to 3.87% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 352.92 Cr → 325.32 Cr (in ₹), with an average decrease of 7.8% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 18.56% to 16.73% in Dec 2024 quarter
Metropolis Healthcare Ltd Financials
Index Inclusions
Metropolis Healthcare Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.4% | ||
| Foreign Institutions | 16.73% | ||
| Mutual Funds | 26.37% | 8.38 | |
| Retail Investors | 3.87% | ||
| Others | 3.63% |
Metropolis Healthcare Ltd Key Indicators
Metropolis Healthcare Ltd Valuation
Metropolis Healthcare Ltd in the last 5 years
Lowest (33.38x)
June 22, 2022
Today (55.46x)
February 19, 2025
Industry (92.99x)
February 19, 2025
Highest (98.05x)
September 15, 2020
Metropolis Healthcare Ltd Earnings and Dividends
Metropolis Healthcare Ltd Earnings Results
Metropolis Healthcare Ltd’s net profit jumped 15.46% since last year same period to ₹31.36Cr in the Q3 2024-2025. On a quarterly growth basis, Metropolis Healthcare Ltd has generated -32.59% fall in its net profits since last 3-months.
Read More about Earnings ResultsMetropolis Healthcare Ltd Dividends November,2023
In the quarter ending September 2023, Metropolis Healthcare Ltd has declared dividend of ₹4 - translating a dividend yield of 0.72%.
Read More about Dividends
Metropolis Healthcare Ltd Technicals Summary
Bearish
Neutral
Bullish
Metropolis Healthcare Ltd is currently in a Bearish trading position according to technical analysis indicators.
Metropolis Healthcare Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹8,453.18 Cr | -1.96% | 0.58 | ₹128 Cr | ₹1,207 Cr | |
| BUY | ₹9,521.57 Cr | 9.92% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹3,805.61 Cr | 3.46% | 0.54 | ₹69 Cr | ₹571 Cr | |
| HOLD | ₹21,840.22 Cr | 12.28% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹29,483.63 Cr | 104.16% | 0.67 | ₹168 Cr | ₹5,040 Cr |
About Metropolis Healthcare Ltd
The company offers a wide range of products and services, including clinical laboratory services, imaging services, pathology services, and wellness services. Metropolis Healthcare Ltd also provides a range of specialty services, such as genetic testing, molecular diagnostics, and bio-banking. It is one of the leading providers of healthcare services in India.
The company's top products include clinical laboratory tests, imaging services, pathology services, and wellness services. It also offers a range of popular services under the brands: Metropolis, Metropolis Health Plus, Metropolis Health Care, and Metropolis Health Care Plus.
Share Price: ₹1678.10 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹8,453.18Cr as of today
Revenue: ₹322.77Cr as on December 2024 (Q4 24)
Net Profit: ₹31.47Cr as on December 2024 (Q4 24)
Listing date: 15 Apr, 2019
Chairperson Name: Sushil Kanubhai Shah
| Organisation | Metropolis Healthcare Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
FAQs on Metropolis Healthcare Ltd
What is Metropolis Healthcare Ltd price today?
Metropolis Healthcare Ltd share price today stands at ₹1678.1, Open: ₹1648.4, Previous Close: ₹1648.4, High: ₹1704.75, Low: ₹1625, 52 Week High: ₹2318.3, 52 Week Low: ₹1551.05.
How to Buy Metropolis Healthcare Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Metropolis Healthcare Ltd shares
Is Metropolis Healthcare Ltd listed on NSE?
Metropolis Healthcare Ltd is listed on NSE
Is Metropolis Healthcare Ltd listed on BSE?
Metropolis Healthcare Ltd is listed on BSE
What are today's High and Low prices of Metropolis Healthcare Ltd?
- Today's highest price of Metropolis Healthcare Ltd is ₹1704.75.
- Today's lowest price of Metropolis Healthcare Ltd is ₹1625.
What are today's traded volumes of Metropolis Healthcare Ltd?
Today's traded volume of Metropolis Healthcare Ltd(METROPOLIS) is 4.01L.
What is today's market capitalisation of Metropolis Healthcare Ltd?
Today's market capitalisation of Metropolis Healthcare Ltd(METROPOLIS) is ₹8453.18Cr.
What is the 52 Week High and Low Range of Metropolis Healthcare Ltd?
How much percentage Metropolis Healthcare Ltd is down from its 52 Week High?
Metropolis Healthcare Ltd (METROPOLIS) share price is ₹1678.1. It is down -27.62% from its 52 Week High price of ₹2318.3
How much percentage Metropolis Healthcare Ltd is up from its 52 Week low?
Metropolis Healthcare Ltd (METROPOLIS) share price is ₹1678.1. It is up 8.19% from its 52 Week Low price of ₹1551.05
What are the historical returns of Metropolis Healthcare Ltd?
What is the PE ratio of Metropolis Healthcare Ltd today?
PE Ratio of Metropolis Healthcare Ltd is 55.46
PE ratio = Metropolis Healthcare Ltd Market price per share / Metropolis Healthcare Ltd Earnings per share